Dr. Giulio Paciotti
VICE PRESIDENT R&D
Scientist n tumor biology
Imagion Biosystems
United States of America
Biography
Dr. Paciotti is an accomplished scientist in tumor biology and the development of nanotechnologies for the early diagnosis and treatment of cancer. Prior to joining Imagion Biosystems Dr. Paciotti had developed a gold nanoparticle-based therapeutic. Currently he leads Imagion’s team in developing the MagSense™ technology for the detection of early stage and disseminated cancers. Complimenting his scientific credentials is a 15-year record of bringing complex nanomedicines through the regulatory process including cGMP manufacturing and analytical program development, toxicology and IND (IDE) submission. Dr. Paciotti holds multiple patents in nanotechnology for use in oncology, drug delivery, cancer detection, human monoclonal antibody generation, infectious disease and biodefense. Dr. Paciotti received his PhD from the University of Maryland at College Park.
Research Interest
Nanotechnology for use in oncology, drug delivery, cancer detection, human monoclonal antibody generation, infectious disease and biodefense
